Doorgaan naar hoofdcontent

Simparica Trio - opinion on variation to marketing authorisation | European Medicines Agency (EMA)

Simparica Trio - opinion on variation to marketing authorisation | European Medicines Agency (EMA)

On 12 February 2025, the Committee for Veterinary Medicinal Products (CVMP) adopted a positive opinion1, recommending the granting of a variation to the terms of the marketing authorisation for the veterinary medicinal product Simparica Trio. The mar

Lees verder »
Wil je het laatste nieuws in jouw mailbox? Meld je dan aan voor de nieuwsbrief